Product Search |
Products |
|
Products |
|
No. | CPTA003 |
Products | Imatinib mesylate |
Synonyms | N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4-(4-methylpiperazin-1-yl)benzamide methanesulfonate |
Cas No. | 220127-57-1 |
Molecular Formula | C30H35N7O4S |
Molecular Weight | 589.71 |
Assay | 99.7% |
Usage | Used in the treatment of chronic myelogenous leukemia (CML) rapidly varied period, acceleration peri |
Molecular Structure | |
Imatinib mesylate in May at the cellular level in vivo and in vitro inhibition of Bcr - Abl tyrosine kinase, can selectively inhibit Bcr - Abl, Ph chromosome positive positive cell line cells of chronic myeloid leukemia and acute lymphoblastic leukemia patient fresh cell proliferation and induce its apoptosis. Moreover, imatinib mesylate can inhibit platelet derivation growth factor (PDGF) receptors, stem cell factor (SCF), c - Kit receptor tyrosine kinase, thus inhibiting by PDGF and stem cell factor mediating cell behavior. |
|
|
|